vTv Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$20,250,000 over the previous period. Total operating expenses were $11,907,000.
Profit Margin
| 2014 | 1.54M | -36.10M | -2330.6% |
|---|---|---|---|
| 2015 | 519K | -27.49M | -5298.27% |
| 2016 | 634K | -16.35M | -2579.18% |
| 2017 | 291K | -16.14M | -5547.77% |
| 2018 | 12.43M | -7.91M | -63.62% |
| 2019 | 2.76M | -21.93M | -793.7% |
| 2020 | 6.41M | -8.82M | -137.62% |
| 2021 | 4.00M | -17.73M | -442.72% |
| 2022 | 2.01M | -25.07M | -1242.47% |
| 2023 | 0 | -20.25M |
VTVT Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 2.01M | 4.00M | 6.41M | 2.76M | 12.43M | 291K | 634K | 519K | 1.54M |
Cost of revenue | 13.59M | 92K | 89K | 11.01M | 15.11M | 0 | 39.64M | 0 | 29.58M | 18.72M |
Gross profit | -13.59M | 1.92M | 3.91M | -4.60M | -12.35M | 12.43M | -39.34M | 634K | -29.06M | -17.18M |
Operating exp. | ||||||||||
Research and development | 13.59M | 12.35M | 13.32M | 11.01M | 15.11M | 23.03M | 39.64M | 45.74M | 29.58M | 18.72M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 11.90M | 24.55M | 25.66M | 18.26M | 23.65M | 32.25M | 50.97M | 55.65M | 38.66M | 30.44M |
Operating income | -25.50M | -22.54M | -21.66M | -11.85M | -20.89M | -19.82M | -50.68M | -55.02M | -38.14M | -28.89M |
Other income (expenses), net | -464K | -2.33M | 4.04M | -950K | -946K | -592K | -3.16M | -22K | -2.96M | -7.20M |
Income before tax | -25.96M | -24.87M | -17.61M | -12.80M | -21.83M | -23.64M | -53.84M | -55.35M | -41.10M | -36.10M |
Income tax expense | 0 | 200K | 115K | -3.97M | 100K | 200K | 800K | -39.00M | -14.11M | 4.88M |
Net income | -20.25M | -25.07M | -17.73M | -8.82M | -21.93M | -7.91M | -16.14M | -16.35M | -27.49M | -36.10M |
Earnings per share | ||||||||||
Basic EPS | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 | -66.62 | -68.52 | -132.9 | -173.87 |
Diluted EPS | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 | -66.62 | -68.52 | -132.9 | -173.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |